다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기
The Journal of infection, v.71 suppl.1, 2015년, pp.S80 - S87
Mejias, A. , Ramilo, O.
AI-Helper
Respiratory syncytial virus (RSV) remains a significant cause of morbidity and mortality in infants, immunocompromised patients and the elderly. Despite the high disease burden, an effective vaccine or specific therapy are lacking which is largely due to our limited understanding of the immune respo...
J Gen Virol Heidema 85 Pt 8 2365 2004 10.1099/vir.0.80131-0 Human CD8(+) T cell responses against five newly identified respiratory syncytial virus-derived epitopes
Virology Rutigliano 337 2 335 2005 10.1016/j.virol.2005.04.032 Identification of an H-2D(b)-restricted CD8+ cytotoxic T lymphocyte epitope in the matrix protein of respiratory syncytial virus
Proc Natl Acad Sci USA Magro 109 8 3089 2012 10.1073/pnas.1115941109 Neutralizing antibodies against the preactive form of respiratory syncytial virus fusion protein offer unique possibilities for clinical intervention
Science McLellan 340 6136 1113 2013 10.1126/science.1234914 Structure of RSV fusion glycoprotein trimer bound to a prefusion-specific neutralizing antibody
Nature Corti 501 7467 439 2013 10.1038/nature12442 Cross-neutralization of four paramyxoviruses by a human monoclonal antibody
Pediatrics Garcia 126 6 e1453 2010 10.1542/peds.2010-0507 Risk factors in children hospitalized with RSV bronchiolitis versus non-RSV bronchiolitis
N Engl J Med Hall 360 6 588 2009 10.1056/NEJMoa0804877 The burden of respiratory syncytial virus infection in young children
Lancet Stein 354 9178 541 1999 10.1016/S0140-6736(98)10321-5 Respiratory syncytial virus in early life and risk of wheeze and allergy by age 13 years
Lancet Nair 375 9725 1545 2010 10.1016/S0140-6736(10)60206-1 Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis
JAMA Shay 282 15 1440 1999 10.1001/jama.282.15.1440 Bronchiolitis-associated hospitalizations among US children, 1980-1996
Lancet Lozano 380 9859 2095 2012 10.1016/S0140-6736(12)61728-0 Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010
Infect Disord Drug Targets Walsh 12 2 98 2012 10.2174/187152612800100116 Respiratory syncytial virus infection in adult populations
J Infect Dis Campbell 201 9 1404 2010 10.1086/651662 Respiratory virus pneumonia after hematopoietic cell transplantation (HCT): associations between viral load in bronchoalveolar lavage samples, viral RNA detection in serum samples, and clinical outcomes of HCT
Am J Dis Child Glezen 140 6 543 1986 Risk of primary infection and reinfection with respiratory syncytial virus
J Infect Dis Hall 163 4 693 1991 10.1093/infdis/163.4.693 Immunity to and frequency of reinfection with respiratory syncytial virus
Clin Infect Dis Kristensen 54 6 810 2012 10.1093/cid/cir928 Chronic diseases, chromosomal abnormalities, and congenital malformations as risk factors for respiratory syncytial virus hospitalization: a population-based cohort study
J Infect Dis DeVincenzo 191 11 1861 2005 10.1086/430008 Respiratory syncytial virus load predicts disease severity in previously healthy infants
J Med Virol Houben 82 7 1266 2010 10.1002/jmv.21771 Disease severity and viral load are correlated in infants with primary respiratory syncytial virus infection in the community
Pediatr Infect Dis J Larranaga 28 10 867 2009 10.1097/INF.0b013e3181a3ea71 Impaired immune response in severe human lower tract respiratory infection by respiratory syncytial virus
Pediatr Infect Dis J Sheeran 18 2 115 1999 10.1097/00006454-199902000-00007 Elevated cytokine concentrations in the nasopharyngeal and tracheal secretions of children with respiratory syncytial virus disease
J Infect Dis Bennett 195 10 1532 2007 10.1086/515575 Immunopathogenesis of respiratory syncytial virus bronchiolitis
J Infect Dis El Saleeby 204 7 996 2011 10.1093/infdis/jir494 Respiratory syncytial virus load, viral dynamics, and disease severity in previously healthy naturally infected children
Diagn Microbiol Infect Dis Martin 62 4 382 2008 10.1016/j.diagmicrobio.2008.08.002 Clinical disease and viral load in children infected with respiratory syncytial virus or human metapneumovirus
J Infect Dis Wright 185 8 1011 2002 10.1086/339822 Illness severity, viral shedding, and antibody responses in infants hospitalized with bronchiolitis caused by respiratory syncytial virus
J Infect Dis Hasegawa 211 10 1550 2015 10.1093/infdis/jiu658 Respiratory syncytial virus genomic load and disease severity among children hospitalized with bronchiolitis: multicenter cohort studies in the United States and Finland
Mejias 2010 Infectious Diseases Society of America 48th Annual Meeting Respiratory syncytial virus (RSV) genetic variability and viral loads do not correlate with disease severity in children hospitalized with bronchiolitis
Pediatr Infect Dis J Jafri 32 4 335 2013 10.1097/INF.0b013e318282603a Distribution of respiratory syncytial virus subtypes A and B among infants presenting to the emergency department with lower respiratory tract infection or apnea
Pediatr Infect Dis J Garcia 31 1 86 2012 10.1097/INF.0b013e31822dc8c1 Decreased innate immune cytokine responses correlate with disease severity in children with respiratory syncytial virus and human rhinovirus bronchiolitis
Influenza Other Respir Viruses Mehta 8 6 617 2014 10.1111/irv.12276 Lactate dehydrogenase and caspase activity in nasopharyngeal secretions are predictors of bronchiolitis severity
J Infect Dis Mella 207 4 564 2013 10.1093/infdis/jis721 Innate immune dysfunction is associated with enhanced disease severity in infants with respiratory syncytial virus bronchiolitis
J Infect Dis Mella 208 11 1924 2013 10.1093/infdis/jit514 Reply to Plotz et al
Pediatr Infect Dis J Bucasas 32 2 e68 2013 10.1097/INF.0b013e318278b4b3 Global gene expression profiling in infants with acute respiratory syncytial virus broncholitis demonstrates systemic activation of interferon signaling networks
J Virol Ioannidis 86 10 5422 2012 10.1128/JVI.06757-11 Plasticity and virus specificity of the airway epithelial cell immune response during respiratory virus infection
Mejias 2010 Children with bronchiolitis. Pediatric Academic Societies Annual Meeting; Vancouver, BC, Canada Abstract No 707 Can disease activity be measured at the molecular level? Molecular distance to health assesses respiratory syncytial virus (RSV) disease severity
Pediatrics Ralston 134 5 e1474 2014 10.1542/peds.2014-2742 Clinical practice guideline: the diagnosis, management, and prevention of bronchiolitis
Evid Based Child Health: a Cochrane review journal Emmett 9 2 301 2014 10.1002/ebch.1964 Bronchodilators for bronchiolitis-should they be used routinely?:...reducing waste in child health one intervention at a time
Pediatrics Chowdhury 131 4 661 2013 10.1542/peds.2012-1317 Heliox therapy in bronchiolitis: phase III multicenter double-blind randomized controlled trial
Cochrane Database Syst Rev Zhang 2008 10.1002/14651858.CD006458.pub2 Nebulized hypertonic saline solution for acute bronchiolitis in infants
J Infect Dis Buckingham 185 9 1222 2002 10.1086/340024 A randomized, double-blind, placebo-controlled trial of dexamethasone in severe respiratory syncytial virus (RSV) infection: effects on RSV quantity and clinical outcome
Crit Care Med van Woensel 39 7 1779 2011 10.1097/CCM.0b013e318218a030 Dexamethasone in children mechanically ventilated for lower respiratory tract infection caused by respiratory syncytial virus: a randomized controlled trial
N Engl J Med Plint 360 20 2079 2009 10.1056/NEJMoa0900544 Epinephrine and dexamethasone in children with bronchiolitis
N Engl J Med Corneli 357 4 331 2007 10.1056/NEJMoa071255 A multicenter, randomized, controlled trial of dexamethasone for bronchiolitis
Pediatr Allergy Immunol: official publication of the European Society of Pediatric Allergy and Immunology Somers 20 5 477 2009 10.1111/j.1399-3038.2009.00852.x Effect of dexamethasone on respiratory syncytial virus-induced lung inflammation in children: results of a randomized, placebo controlled clinical trial
Am J Respir Crit Care Med Bisgaard 178 8 854 2008 10.1164/rccm.200706-910OC Study of montelukast for the treatment of respiratory symptoms of post-respiratory syncytial virus bronchiolitis in children
Cochrane Database Syst Rev 2004 Ribavirin for respiratory syncytial virus infection in the lower respiratory tract in infants and young children
American Academy of Pediatrics 609 2012 Red Book: 2012 report of the committee on infectious diseases Respiratory syncytial virus
Pediatrics 99 1 93 1997 10.1542/peds.99.1.93 Reduction of respiratory syncytial virus hospitalization among premature infants and infants with bronchopulmonary dysplasia using respiratory syncytial virus immune globulin prophylaxis. The PREVENT Study Group
Pediatrics 102 3 531 1998 10.1542/peds.102.3.531 Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants
J Pediatr Feltes 143 4 532 2003 10.1067/S0022-3476(03)00454-2 Palivizumab prophylaxis reduces hospitalization due to respiratory syncytial virus in young children with hemodynamically significant congenital heart disease
Pediatrics Carbonell-Estrany 125 1 e35 2010 10.1542/peds.2008-1036 Motavizumab for prophylaxis of respiratory syncytial virus in high-risk children: a noninferiority trial
Pediatrics American Academy of Pediatrics Committee on Infectious D, American Academy of Pediatrics Bronchiolitis Guidelines C 134 2 415 2014 10.1542/peds.2014-1665 Updated guidance for palivizumab prophylaxis among infants and young children at increased risk of hospitalization for respiratory syncytial virus infection
Vaccine Anderson 31 Suppl. 2 B209 2013 10.1016/j.vaccine.2012.11.106 Strategic priorities for respiratory syncytial virus (RSV) vaccine development
Clin Infect Dis Empey 50 9 1258 2010 10.1086/651603 Pharmacologic advances in the treatment and prevention of respiratory syncytial virus
Blood Shah 117 10 2755 2011 10.1182/blood-2010-08-263400 Management of RSV infections in adult recipients of hematopoietic stem cell transplantation
Pediatr Infect Dis J Ramilo 33 7 703 2014 10.1097/INF.0000000000000240 Motavizumab treatment of infants hospitalized with respiratory syncytial virus infection does not decrease viral load or severity of illness
Antimicrob Agents Chemother Robbie 57 12 6147 2013 10.1128/AAC.01285-13 A novel investigational Fc-modified humanized monoclonal antibody, motavizumab-YTE, has an extended half-life in healthy adults
Ulbrandt 2014 9th International Respiratory Syncytial Virus Symposium; Cape Town, South Africa Abstract OP 27 A next generation anti-RSV F monoclonal antibody as passive immunization for prevention of RSV disease in all infants
J Infect Dis Haynes 200 3 439 2009 10.1086/600108 Therapeutic monoclonal antibody treatment targeting respiratory syncytial virus (RSV) G protein mediates viral clearance and reduces the pathogenesis of RSV infection in BALB/c mice
Detalle 2014 9th International Respiratory Syncytial Virus Symposium; Cape Town, South Africa Abstract OP 72 Delivery of ALX-0171 by inhalation greatly reduces disease burden in a neonatal lamb RSV infection model
N Engl J Med DeVincenzo 371 8 711 2014 10.1056/NEJMoa1401184 Oral GS-5806 activity in a respiratory syncytial virus challenge study
Curr Opin Drug Discov Dev Bonfanti 12 4 479 2009 Prospects for the development of fusion inhibitors to treat human respiratory syncytial virus infection
J Med Chem Bonfanti 51 4 875 2008 10.1021/jm701284j Selection of a respiratory syncytial virus fusion inhibitor clinical candidate. 2. Discovery of a morpholinopropylaminobenzimidazole derivative (TMC353121)
Curr Top Microbiol Immunol Chu 372 235 2013 Respiratory syncytial virus disease: prevention and treatment
Proc Natl Acad Sci USA DeVincenzo 107 19 8800 2010 10.1073/pnas.0912186107 A randomized, double-blind, placebo-controlled study of an RNAi-based therapy directed against respiratory syncytial virus
Am J Respir Crit Care Med Zamora 183 4 531 2011 10.1164/rccm.201003-0422OC RNA interference therapy in lung transplant patients infected with respiratory syncytial virus
Devincenzo 2014 Treatment with oral ALS-008176, a nucleoside analog, rapidly reduces RSV viral load and clinical disease severity in a healthy volunteer challenge study
Antimicrob Agents Chemother Chapman 51 9 3346 2007 10.1128/AAC.00211-07 RSV604, a novel inhibitor of respiratory syncytial virus replication
Antimicrob Agents Chemother Challa 2014 Mechanism of action for respiratory syncytial virus inhibitor RSV604
Am J Respir Crit Care Med DeVincenzo 182 10 1305 2010 10.1164/rccm.201002-0221OC Viral load drives disease in humans experimentally infected with respiratory syncytial virus
J Infect Dis Jafri 189 10 1856 2004 10.1086/386372 Respiratory syncytial virus induces pneumonia, cytokine response, airway obstruction, and chronic inflammatory infiltrates associated with long-term airway hyperresponsiveness in mice
Antimicrob Agents Chemother Mejias 48 5 1811 2004 10.1128/AAC.48.5.1811-1822.2004 Anti-respiratory syncytial virus (RSV) neutralizing antibody decreases lung inflammation, airway obstruction, and airway hyperresponsiveness in a murine RSV model
Antimicrob Agents Chemother Mejias 49 11 4700 2005 10.1128/AAC.49.11.4700-4707.2005 Comparative effects of two neutralizing anti-respiratory syncytial virus (RSV) monoclonal antibodies in the RSV murine model: time versus potency
J Pediatr Simoes 151 1 34 2007 10.1016/j.jpeds.2007.02.032 Palivizumab prophylaxis, respiratory syncytial virus, and subsequent recurrent wheezing
J Allergy Clin Immunol Simoes 126 2 256 2010 10.1016/j.jaci.2010.05.026 The effect of respiratory syncytial virus on subsequent recurrent wheezing in atopic and nonatopic children
N Engl J Med Blanken 368 19 1791 2013 10.1056/NEJMoa1211917 Respiratory syncytial virus and recurrent wheeze in healthy preterm infants
해당 논문의 주제분야에서 활용도가 높은 상위 5개 콘텐츠를 보여줍니다.
더보기 버튼을 클릭하시면 더 많은 관련자료를 살펴볼 수 있습니다.
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
Copyright KISTI. All Rights Reserved.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.